Phenotypic screening
The centre focuses on rebalancing the current emphasis on target-based screening to identify new pharmaceuticals for complex human diseases.
Source: LinkedIn company description · Retrieved October 13, 2026
The National Phenotypic Screening Centre is a drug discovery venture embedded in the academic sector.
Its main screening facility is at the University of Dundee in Scotland, with a smaller satellite facility at the University of Oxford. NPSC works closely with an assay development hub at the University of Edinburgh.
Based on the company’s public LinkedIn information, supplied through RevenueBase.
The centre focuses on rebalancing the current emphasis on target-based screening to identify new pharmaceuticals for complex human diseases.
Source: LinkedIn company description · Retrieved October 13, 2026
Its approaches use advances spanning genetics, stem cell biology, tissue and organ culture, high-content imaging, high-throughput flow cytometry, label-free screening, informatics and modeling, and small-molecule technologies.
Source: LinkedIn company description · Retrieved October 13, 2026
Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.
Positions describe ordering within each source list. See how lists are built ↗
Embeddable award for your website
Snapshot: September 18, 2026
RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 3, 2026. Directory positions use company-contact counts from separate saved list snapshots dated September 18, 2026. How the company lists are built.
Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.
Explore more companies by name, headquarters and business focus.